Opko Health Inc (OPK) Stock Price, Quote & News

Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 305 575 4100

Website: www.opko.com

Address:

4400 Biscayne Boulevard, Miami, United States

Brasil07 Jan. 14 at 8:00 PM

$OPK This stock make impossible to see the quote every day or between 1 year, because year After year, the quote Is Always among 1,25/1,35

0 · Reply

Liorkd Jan. 14 at 6:33 PM

$OPK how can we ear it today ?

0 · Reply

Indyshaw Jan. 14 at 5:12 PM

$OPK Just throwing this out there. Regeneron always does a deep dive into who they collaborate with.

0 · Reply

tymtested Jan. 14 at 12:47 PM

$OPK will narrative around opko improve today… very possibly!

1 · Reply

Mike18181 Jan. 14 at 12:26 AM

$OPK PO+OPK+O = Poopko💩 the logo shows the Mission statement is to be a dump. To not move ! A pile of Poop ! Paracitic activity.

0 · Reply

Sierradude Jan. 13 at 11:01 PM

$OPK Indeed it is a never ending shit show...designed to benefit a very close knit group of shorts.... the Nevada partnership. Like George Carlin said "It's a small club and you aint in it!" Only hope there is , is Frost departure.

0 · Reply

Mike18181 Jan. 13 at 8:24 PM

$OPK Awarded Nightmare of the year award ! For continued misleading and non delivery. They delivered for the Club/board. This is why the Presidente wont show his face. Hes ashamed he cant deliver. ROE. Return on Equity forcshareholders is Wiped out with -2.3 Billion in accumukated losses since 2006 translation is 1.33

0 · Reply

Brasil07 Jan. 13 at 6:04 PM

$OPK I never Seen in my long Life, a Nightmare like this stock,it's a never ending shit!!

1 · Reply

Biotechguy21 Jan. 13 at 4:31 PM

$OPK ceo in jail yet?

0 · Reply

LongAllDay Jan. 13 at 2:35 PM

$OPK if you want to hedge the AI trade this is the place to be. No AI + No Revenue + No CEO/Leadership Team. Has anyone seen OPKO & Drying Paint in the same room cause I swear they are the same person!!!!

0 · Reply

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Nov 19, 2025, 4:05 PM EST - 2 months ago

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Oct 29, 2025, 9:36 PM EDT - 2 months ago

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 2 months ago

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Oct 22, 2025, 4:05 PM EDT - 3 months ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Sep 15, 2025, 8:30 AM EDT - 4 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Jul 31, 2025, 9:19 PM EDT - 5 months ago

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 5 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 30, 2025, 8:01 AM EDT - 7 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

Jun 25, 2025, 11:00 AM EDT - 7 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

May 15, 2025, 8:00 AM EDT - 8 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

Apr 30, 2025, 7:52 PM EDT - 9 months ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 4, 2025, 8:00 AM EDT - 10 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025, 8:57 AM EDT - 10 months ago

OPKO and Entera partner to develop obesity pill

Mar 11, 2025, 7:00 AM EDT - 11 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Feb 27, 2025, 7:12 PM EST - 11 months ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:10 PM EST - 11 months ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Jan 9, 2025, 11:45 AM EST - 1 year ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 18, 2024, 8:00 AM EST - 1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

Nov 14, 2024, 6:00 AM EST - 1 year ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

Nov 7, 2024, 8:30 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

May 31, 2024, 10:48 AM EDT - 1 year ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 5, 2024, 8:52 AM EST - 2 years ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 27, 2024, 8:08 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024, 4:05 PM EST - 2 years ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Jan 9, 2024, 4:05 PM EST - 2 years ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 4, 2024, 11:31 PM EST - 2 years ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 2 years ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023, 7:00 AM EST - 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Oct 31, 2023, 8:00 AM EDT - 2 years ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 25, 2023, 4:25 PM EDT - 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 20, 2023, 1:30 PM EDT - 2 years ago

OPKO Health: FDA Approval To Save The Company

Sep 28, 2023, 4:08 PM EDT - 2 years ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Aug 4, 2023, 12:17 AM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

Jul 31, 2023, 2:19 PM EDT - 2 years ago

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

Jul 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Brasil07 Jan. 14 at 8:00 PM

$OPK This stock make impossible to see the quote every day or between 1 year, because year After year, the quote Is Always among 1,25/1,35

0 · Reply

Liorkd Jan. 14 at 6:33 PM

$OPK how can we ear it today ?

0 · Reply

Indyshaw Jan. 14 at 5:12 PM

$OPK Just throwing this out there. Regeneron always does a deep dive into who they collaborate with.

0 · Reply

tymtested Jan. 14 at 12:47 PM

$OPK will narrative around opko improve today… very possibly!

1 · Reply

Mike18181 Jan. 14 at 12:26 AM

$OPK PO+OPK+O = Poopko💩 the logo shows the Mission statement is to be a dump. To not move ! A pile of Poop ! Paracitic activity.

0 · Reply

Sierradude Jan. 13 at 11:01 PM

0 · Reply

Mike18181 Jan. 13 at 8:24 PM

0 · Reply

Brasil07 Jan. 13 at 6:04 PM

$OPK I never Seen in my long Life, a Nightmare like this stock,it's a never ending shit!!

1 · Reply

Biotechguy21 Jan. 13 at 4:31 PM

$OPK ceo in jail yet?

0 · Reply

LongAllDay Jan. 13 at 2:35 PM

0 · Reply

tymtested Jan. 13 at 1:44 AM

$OPK let’s see if we get some good news Thursday.

0 · Reply

steviem Jan. 12 at 8:37 PM

$OPK I wonder if Frost will know he's going to hell for destroying so many peoples' lives when he's gasping his final, pathetic breath.

0 · Reply

Brasil07 Jan. 12 at 5:06 PM

$OPK Bastaaaaaaaaaaaaaaa

0 · Reply

tymtested Jan. 10 at 3:17 PM

$OPK OPK is now sporting a RECORD HIGH Equity rating of 7.9!! BULLISH

1 · Reply

Brasil07 Jan. 9 at 9:00 PM

$OPK Seven hours of market, all between 1,34/1,3......Simply incredibile!

0 · Reply

Nvidiagh Jan. 9 at 4:43 PM

$ASTS $OPK CEO buys

0 · Reply

Nvidiagh Jan. 9 at 4:43 PM

$OPEN vs $OPK !

0 · Reply

Tothemoonemoji Jan. 8 at 9:01 PM

$OPK Nice 473k share buy at 1.37

0 · Reply

magadog Jan. 7 at 9:51 PM

$OPK Frost may be buying some cocrystal stock.. It is a tiny groups but it stock seems to follow OPK. Began at $20 and walked down to $0.87. I should have jumped on his WGS investment, Gotta wonder if this 11 person company has a future. other than is it s small cousin go OPK

1 · Reply

tymtested Jan. 7 at 2:37 PM

$OPK Well, lets hope that Frost's purchases of over 2M shares and the volume spikes over the recent trading days are positive leading indicators for what may be in the upcoming presentation.

0 · Reply

r23lis Jan. 7 at 10:07 AM

$OPK

0 · Reply

Brasil07 Jan. 6 at 6:40 PM

$OPK I only know that my Money stuck in Opko, should be put in whatever other share....I should be milionaire !!

0 · Reply

Market Cap	1.02B
Revenue (ttm)	713.14M
Net Income (ttm)	-53.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7.46%
Debt to Equity Ratio	0.19

Volume	2,756,900
Avg Vol	3,288,512
Day's Range	N/A - N/A
Shares Out	767.70M
Stochastic %K	74%
Beta	1.39
Analysts	Strong Sell
Price Target	$2.57